Anthrax

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax

  This is an observational study evaluating raxibacumab for sporadic systemic anthrax cases, sponsored by Emergent BioSolutions, and not yet r…

• CLINICAL_TRIALS research · 2026-03-06
  Clinical Trial Update: Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients

  Clinical trial update for the SPoRE natural history study of anthrax and an evaluation of AVA-vaccinated recipients. Sponsored by NIAID, wit…

• CLINICAL_TRIALS research · 2026-02-06
  Clinical Trial Update: Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

  Observational study evaluating the clinical benefit and safety of AIGIV (ANTHRASIL) in patients with systemic anthrax; sponsor Emergent BioS…

• CLINICAL_TRIALS research · 2025-12-08
  Clinical Trial Update: Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

  This clinical trial is evaluating the clinical benefit and safety of CYFENDUS for post-exposure prophylaxis of anthrax and is currently not …

• CLINICAL_TRIALS research · 2015-04-07
  Clinical Trial Update: VHA Clinicians and Bioterror Events: Interactive Web-based Learning [NA]

  Completed clinical trial evaluating an interactive web-based learning module for VA clinicians on bioterror events related to smallpox and a…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.